F31.0 F31.1 F31.2 F31.3 F31.4 F31.5 F31.6 F31.7 F31.8 F31.9 F32.0 F32.1 F32.8 F32.9 F33.0 F33.1 F33.4 F33.8 F33.9 F34.0 F34.1 F34.8 F34.9 F38.0 F38.1 F38.8
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Present diagnosis of depressive disorder(s) (ICD-10: F31.X-F38.X) - and/or elevated depression score (BDI >14) - Age: 18-80 years - Consent to study participation: written and verbal
Exclusion criteria
Exclusion criteria: - Current outpatient psychotherapy - Previous disease(s), with severe cognitive impairment (e.g. dementia) - Presence of the following ICD-10 diagnoses: F32.3, F33.3, F20-29, F10-19 - very advanced severely progredient physical disease - insufficient mobility to visit the practice - insufficient ability to speak the German language
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Examination of the efficacy of psychoeducation regarding depressive symptoms of the patients in the intervention group compared to the control group. Measure: Baseline-adjusted difference of the depression score in the BDI-II between intervention and control group 1) after psychoeducation/conventional treatment (within the month after completion of the 4th session or 12 weeks after study inclusion) = primary outcome, 2) 3 months after post-measurement (3-month follow-up). 2. Examination of the efficacy concerning patients' self-efficacy in the intervention group compared to the control group. Measure: Baseline-adjusted difference in total FE-RUS score between intervention and control group 1) after psychoeducation/conventional treatment (within the month after completion of the 4th session or 12 weeks after study inclusion) = primary outcome, 2) 3 months after post-measurement (3-month follow-up). 3. Examination of efficacy concerning the increase in depression literacy in comparison to the control group. Measure: Baseline-adjusted difference in total depression literacy questionnaire score (D-Lit-R) between intervention and control group 1) after psychoeducation/conventional treatment (within the month after completion of the 4th session or 12 weeks after study inclusion) = primary outcome, 2) 3 months after post-measurement (3-month follow-up). 4. Examination of the intervention's effect on patient activation. Measure: Baseline-adjusted difference in total score on the PAM- 13 between intervention and control group 1) after psychoeducation/conventional treatment (within the month after completion of the 4th session or 12 weeks after study inclusion) = primary outcome, 2) 3 months after post-measurement (3-month follow-up). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Evaluation of the feasibility of the psychoeducation programme for the general practitioners. 2. Examination of the individual benefit of the programme for the general practitioners. Aims 1 and 2 will be assessed using the general practitioners' feedback questionnaire. 3. Examination of the individual benefit of the programme for the patients. Assessment based on the patients' feedback questionnaire. 4. Exploratory examination of the attitudes of participating general practitioners towards patients with depression. Analysis of the descriptive statistics of the R-DAQ questionnaire. | — |
Countries
Germany
Contacts
Institute of General Practice and Health Services Research, Klinikum rechts der Isar/Technische Universität München